Skip to main content

CORRECTION article

Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1466189

Corrigendum: Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer

Provisionally accepted
Jingtao Sun Jingtao Sun 1Tian Tian Tian Tian 2Naiqiang Wang Naiqiang Wang 1Xuehui Jing Xuehui Jing 3Laiyuan Qiu Laiyuan Qiu 1Haochen Cui Haochen Cui 1Zhao Liu Zhao Liu 1Jikai Liu Jikai Liu 1Lei Yan Lei Yan 1Dawei Li Dawei Li 1*
  • 1 Department of Urology, Qilu Hospital, Shandong University, Jinan, China
  • 2 Department of Respiratory and Critical Care Medicine, Qilu Hospital, Shandong University, Jinan, Shandong Province, China
  • 3 Department of Urology, Yucheng People’s Hospital, Dezhou, China, Dezhou, China

The final, formatted version of the article will be published soon.

    Keywords: Serum sialic acid, Bone Metastases, prostate cancer, Low-volume disease, High-volume disease

    Received: 17 Jul 2024; Accepted: 23 Jul 2024.

    Copyright: © 2024 Sun, Tian, Wang, Jing, Qiu, Cui, Liu, Liu, Yan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Dawei Li, Department of Urology, Qilu Hospital, Shandong University, Jinan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.